From the Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Stroke. 2014 May;45(5):1498-500. doi: 10.1161/STROKEAHA.113.002977. Epub 2014 Mar 27.
It remains uncertain if impaired glucose regulation (IGR) as a predictor for stroke outcomes. This study aimed at observing the effect of IGR on the 1-year outcomes in Chinese patients with ischemic stroke.
Patients with acute ischemic stroke were recruited consecutively in multihospitals across China. Oral glucose tolerance test was performed to identify IGR. Cox proportion hazard model was performed to investigate the effect of IGR on 1-year mortality or stroke recurrence in patients with ischemic stroke.
The study recruited 2639 patients with ischemic stroke. IGR was shown as an independent risk factor for the mortality of patients with ischemic stroke (hazard ratio [95% confidence interval], 3.088 [1.386-6.884]; P=0.006). However, IGR showed no significant effects on the dependency or stroke recurrence of patients (P=0.540 and 0.618, respectively).
IGR was an independent predictor for the mortality of patients with ischemic stroke. IGR should be highlighted and intervened actively in the patients with ischemic stroke.
血糖调节受损(IGR)是否可预测卒中结局仍不确定。本研究旨在观察 IGR 对中国缺血性卒中患者 1 年结局的影响。
连续纳入中国多家医院的急性缺血性卒中患者。行口服葡萄糖耐量试验(OGTT)以明确 IGR。采用 Cox 比例风险模型分析 IGR 对缺血性卒中患者 1 年死亡率或卒中复发的影响。
本研究共纳入 2639 例缺血性卒中患者。IGR 是缺血性卒中患者死亡的独立危险因素(风险比[95%置信区间],3.088[1.386-6.884];P=0.006)。然而,IGR 对患者的依赖或卒中复发无显著影响(P=0.540 和 0.618)。
IGR 是缺血性卒中患者死亡的独立预测因素。应重视 IGR,并积极干预缺血性卒中患者。